J Gen Intern Med:积极选择干预能增加流感疫苗接种率

2017-07-27 顾歆纯 环球医学资讯

2017年7月,发表在《J Gen Intern Med》的一项由美国科学家进行的观察性研究,考察了电子健康记录内积极选择干预与流感疫苗接种率增加的相关性。

2017年7月,发表在《J Gen Intern Med》的一项由美国科学家进行的观察性研究,考察了电子健康记录内积极选择干预与流感疫苗接种率增加的相关性。

背景:尽管流感疫苗具有获益,但是每年超过一半的美国人并未接种它。

目的:旨在评估电子健康记录(EHR)中的积极选择干预与流感疫苗接种率的改变之间的相关性。

设计:观察性研究。

患者:2010年9月~2013年3月,在宾夕法尼亚大学健康系统中1/3的内科就诊患者,均为适合流感疫苗接种的成人。

干预:EHR确认门诊期间符合条件的患者,评估患者记录,提示医生及其助理医师积极选择“接受”或“取消”流感疫苗订单。

主要测量:干预实践中流感疫苗订单率的改变vs 2012~2013年两个流感季的干预实践,比较先前两个流感季期间的趋势,同时调整了时间趋势和患者及门诊特征。

主要结果:样本(45926名患者)的62.9%为女性,35.9%为白人,54.4%为黑人,平均50.2岁。的2年期间干预前的干预与对照组趋势相似。当年干预后的,疫苗接种率增加,但是使用积极选择的干预组比对照组更显著性增加(调整双差:6.6%;95% CI,5.1~8.1;P<0.001),与干预前相比,相对增加了37.3%。研究期间,超过99.9%(9938/9941)的订单转化为实际接种。

结论:通过EHR积极选择与流感疫苗接种率的显著增加相关。

原始出处:

Patel MS, Volpp KG, Small DS, et al.Using Active Choice Within the Electronic Health Record to Increase Influenza Vaccination Rates. J Gen Intern Med.2017 Jul;32(7):790-795. doi: 10.1007/s11606-017-4046-6. Epub 2017 Mar 23.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2019510, encodeId=90d2201951098, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Thu Mar 15 18:47:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078652, encodeId=158e20e865220, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Wed Oct 18 00:47:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257837, encodeId=70e2125e8376f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607891, encodeId=2c95160e89110, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2019510, encodeId=90d2201951098, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Thu Mar 15 18:47:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078652, encodeId=158e20e865220, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Wed Oct 18 00:47:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257837, encodeId=70e2125e8376f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607891, encodeId=2c95160e89110, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=)]
    2017-10-18 gous
  3. [GetPortalCommentsPageByObjectIdResponse(id=2019510, encodeId=90d2201951098, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Thu Mar 15 18:47:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078652, encodeId=158e20e865220, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Wed Oct 18 00:47:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257837, encodeId=70e2125e8376f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607891, encodeId=2c95160e89110, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2019510, encodeId=90d2201951098, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Thu Mar 15 18:47:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078652, encodeId=158e20e865220, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Wed Oct 18 00:47:00 CST 2017, time=2017-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257837, encodeId=70e2125e8376f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607891, encodeId=2c95160e89110, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jul 29 07:47:00 CST 2017, time=2017-07-29, status=1, ipAttribution=)]

相关资讯

J Consult Clin Psychol:患儿父母的教育干预的影响

近期,J Consult Clin Psychol杂志中有一篇文章,对患有哮喘或湿疹的儿童的父母进行了教育干预的研究。目的在于比较教育干预对父母的育儿能力的提升、情绪的调节,对儿童情绪及行为的调节有无相关性。父母在儿童患病后的护理方面扮演着重要的角色,直接影响到儿童的行为及康复。然而,关于父母的教育干预与慢性疾病患儿之间相关关系的研究报道较少。该研究选取了107名确诊为哮喘或湿疹的儿童的父母,随机

Crit Care Med:多层次干预改善重症监护的医疗!

目前,缺乏全面评估中ICU中改善团队沟通、吸引患者和护理伙伴参与的干预措施的相关研究。近期,一项发表在杂志Crit Care Med上的研究探讨了在医疗ICU中,以病人为中心的护理和参与计划的有效性。此项研究为前瞻性干预研究。在大型三级保健中心的医疗ICU中进行。受试对象为自2013年7月至2014年5月和2014年7月至2015年5月期间,两千一百五十名入院患者(干预前为1,030人,干预期间为

Lancet Neurol:药物或生活方式干预真的能影响具有记忆障碍老人的认知功能吗?

尚无大型临床试验证实,特定药物+数种生活方式改善的这一强大干预措施,与安慰剂相比,对老年人预防认知能力下降方面的效果如何。2017年5月,发表在《Lancet Neurol》的一项随机安慰剂对照试验调查了长期ω-3多不饱和脂肪酸补充联合或不联合多因素干预对具有记忆障碍的老人认知功能的影响。

Pharmacotherapy:现有干预措施对自闭症谱系障碍儿童的睡眠问题是否有效?

自闭症谱系障碍(ASD)是一种发育性障碍,其特征包括异常的语言能力、异常的交往能力、狭窄的兴趣以及固执的行为模式。2017年5月,发表在《Pharmacotherapy》的一项由澳大利亚科学家进行的系统评价,考察了闭症谱系障碍儿童基于睡眠的干预措施的有效性。

评价干预措施效果指标解释:RR,ARR,RRR,NNT

假设某研究拟探讨A药对于室性心律失常的治疗效果,试验结果为服用A药的患者10%死亡,对照组20%死亡。那么RR(Relative Risk, 相对危险度)是?很简单:RR=10%/20%=0.5。不了解RR是什么? 一、RR能说明什么? 假设另一项拟探讨B药对于急性心肌梗死的治疗效果,试验结果为服用B药的患者40%死亡,对照组80%死亡。RR=40%/80%=0.5。(表1) 表1. 两种药

CA Cancer J Clin:肿瘤领域中的家庭护理干预试验

本文包含了2010年至2016年发表于肿瘤学关于家庭护理的文献综述。研究人员共纳入了810项引文和50项随机试验。这些试验描述了家庭护理人员在癌症护理中所扮演的复杂角色。多项研究表明干预措施可改善家庭照顾者的生活质量以及其情感支持。一些研究专注于交流和亲密关系,这是关键的部分。这些试验的另外一个关注点是护理任务的区域以及减少家庭护理人员负担的方式。考虑到门诊护理的转变以及家庭护理人员成为护理的主要